News

Lonza and Medarex have signed an agreement. According to the agreement, Medarex would provide manufacturing services in support of the development and commercialization of Medarex’s pipeline of therapeutic

Osmetech has received FDA 510(k) clearance for its eSensor Cystic Fibrosis Genotyping Test, for use on the eSensor XT-8 System. This multiplex test is used for: cystic fibrosis

Germany-based Bayer Schering Pharma has signed a supply and distribution agreement with the Polish insulin producer, Bioton and its Singapore subsidiary, SciGen, to strengthen its pharmaceutical product portfolio.

AngioChem’s first patent has been granted by the US Patent and Trademark office. US Patent Number 7557182 is entitled to Aprotinin polypeptides for transporting a compound across the

Millipore and BioTime’s subsidiary, Embryome Sciences have entered into a co-marketing agreement. Under the agreement, Millipore would become a worldwide distributor of ACTCellerate human progenitor cell lines. Donald

Highlights include 11% sequential revenue increase over Q1 2009 and 8% sensor growth compared with Q2 2008, the third consecutive quarter of year over year sensor growth. Sales

FDA has completed its review of PharmAthene’ proposed development plan for SparVax, a recombinant protective antigen (rPA) anthrax vaccine. In response to amendments to the request for proposal

Chattem has reported an increase in total revenue by 4.4% to $121.8 million for the second quarter of fiscal 2009, as compared to $116.7 million in the prior

Sciele and Victory Pharma have mutually agreed to terminate their previously announced merger agreement, due to the occurrence of an unforeseen development that occurred after the agreement was